Health Condition 1: E282- Polycystic ovarian syndrome
Conditions
Interventions
Intervention1: UNANI FORMULATION (HERBAL SYRUP): HERBAL SYRUP WILL BE GIVEN 20ML TWICE DAILY FOR 56 DAYS
Control Intervention1: TABLET METFORMIN 500MG: TABLET METFORMIN 500MG WILL BE GIVEN TWICE DAILY
Sponsors
NATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS HYDERABAD
Eligibility
Inclusion criteria
Inclusion criteria: Participants of PCOS as diagnosed by Rotterdam Criteria Clinical Hyperandrogenism or Biochemical Hyperandrogenism (Raised Testosterone) Evidence of Oligo-anovulation Oligo-amenorrhea Amenorrhea Polycystic Ovarian Morphology (PCOM) on USG or BMI
Exclusion criteria
Exclusion criteria: Patients having congenital uterine abnormalities Patients with history of Hormone Replacement Therapy, or using any other long-term medication Patients with known active systemic diseases Known Cases of Hypothyroidism, severe Hyperprolactinemia Diabetes Mellitus and other immunocompromised disorders Pregnant or Lactating women Participants not willing to give consent and to attend treatment schedule regularly
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resumption of Normal, Ovulatory Menstrual Cycles Reduction in Serum Testosterone LevelTimepoint: At baseline and on 2nd, 4th, 6th and 8th weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in Modified Ferriman Gallwey Hirsutism Score Changes in PCOM on USG Changes in Body Mass Index (BMI) & Waist/Hip Ratio Assessment of Adverse Events at every follow-up visitTimepoint: At baseline & on 8th week | — |
Countries
India
Contacts
Public ContactPROF QAMAR UDDIN
NATIONAL RESEARCH INSTITUTE OF UNANI MEDICINE FOR SKIN DISORDERS, HYDERABAD
Outcome results
None listed